相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years
Neelam Desai et al.
CANCER (2021)
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)
Tuya Pal et al.
GENETICS IN MEDICINE (2020)
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
Siddhartha Yadav et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
CDH1 on Multigene Panel Testing: Look Before You Leap COMMENT
Bryson W. Katona et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
Chunling Hu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
Julie R. Palmer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast Cancer
Stephanie L. Greville-Heygate et al.
JCO PRECISION ONCOLOGY (2020)
Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons
Eric R. Manahan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
Christos Petridis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria
Rosa M. Xicola et al.
JOURNAL OF MEDICAL GENETICS (2019)
Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers
Maegan E. Roberts et al.
JAMA ONCOLOGY (2019)
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
Li Sun et al.
JAMA ONCOLOGY (2019)
Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations
Yoan Ditchi et al.
BREAST JOURNAL (2019)
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D. Beitsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical spectrum and pleiotropic nature of CDH1 germline mutations
Joana Figueiredo et al.
JOURNAL OF MEDICAL GENETICS (2019)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Patient survival and tumor characteristics associated with CHEK2:p.I157T-findings from the Breast Cancer Association Consortium
Taru A. Muranen et al.
BREAST CANCER RESEARCH (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Hereditary Diffuse Gastric Cancer Syndrome CDH1 Mutations and Beyond
Samantha Hansford et al.
JAMA ONCOLOGY (2015)
Lobular breast cancer series: imaging
Karen Johnson et al.
BREAST CANCER RESEARCH (2015)
Lobular breast cancer: incidence and genetic and non-genetic risk factors
Laure Dossus et al.
BREAST CANCER RESEARCH (2015)
Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods
Tatiane M. G. Oliveira et al.
INSIGHTS INTO IMAGING (2014)
The CHEK2 I157T Variant and Breast Cancer Susceptibility: A Systematic Review and Meta-analysis
Chuan Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer
Pawel Domagala et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Serena Masciari et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Nasim Mavaddat et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Germline Mutations of the E-Cadherin Gene in Families With Inherited Invasive Lobular Breast Carcinoma But No Diffuse Gastric Cancer
Ze Ming Xie et al.
CANCER (2011)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Lobular breast carcinoma and its variants
Emad A. Rakha et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2010)
Germline E-cadherin mutations in familial lobular breast cancer
S. Masciari et al.
JOURNAL OF MEDICAL GENETICS (2007)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer
Pardeep Kaurah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Pathology of breast cancer in women with constitutional CHEK2 mutations
T Huzarski et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
CHEK2 variant 1157T may be associated with increased breast cancer risk
O Kilpivaara et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Trends in incidence rates of invasive lobular and ductal breast carcinoma
CI Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
